User menu

Evaluation of the DAS28 at week 14 or week 22 correlates best with long term attrition to infliximab therapy in rheumatoid arthritis patients

Bibliographic reference Cruyssen, B. Vander ; Durez, Patrick ; Van Looy, S. ; Wijns, B. ; Westhovens, Rene ; et. al. Evaluation of the DAS28 at week 14 or week 22 correlates best with long term attrition to infliximab therapy in rheumatoid arthritis patients.Annual European Congress of Rheumatology (EULAR 2006) (Amsterdam (Netherlands), Jun 21-24, 2006). In: Annals of the Rheumatic Diseases, Vol. 65, p. 114-115 (2006)
Permanent URL http://hdl.handle.net/2078.1/59551